Neurite outgrowth Treatment response Lateral diffusion Post-partum GSK-3β Glia Endocannabinoid system Blood brain barrier Cerebrospinal fluid Collapsing response mediator protein Cannabinoid receptor type 2 Astrocyte Anti-GFAP encephalomyelitis Neurological immune-related adverse events Glutamate MRI Autoantibodies MOGAD Blood–brain barrier MOG Circadian clock COVID-19 Optic neuritis NMOSD Connexins Adult neurogenesis Blood-brain barriers Influx constant Relapses MOG-IgG associated disorders MOGAD Cancer immunotherapy Adverse events Encephalitis Neuraxial analgesia Area postrema syndrome Myelin oligodendrocyte glycoprotein Clinically isolated syndrome CIS Neuromyelitis optica Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Neuroinflammation Immunosuppressant Biomarkers Multiple sclerosis MS Toll-like receptor Blood–CSF barrier Breastfeeding Multiple sclerosis Innate immune system Cytokines Bright B cells Aquaporin-4-IgG AQP4-IgG Database Microenvironment Microglia Central nervous system Estradiol Drosophila Rituximab Disease-modifying treatments CD14 Neural antibodies Reproductive assistance Aquaporin-4 antibody Cilia GABA Myelitis Bone Gunn Longitudinally extensive transverse myelitis Biobank Embryo MOG antibodies Cancer Claudin Choroid plexus Ependymal cell Disease modifying treatments Children Registry Prognosis Animal model Amino acid LAT1 Meninges Autoimmune diseases Jaundice Aquaporin-4 antibodies Blood-brain barrier CP Molecular biology Autoimmune encephalitis Aquaporin-4 CRMP5 Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation Hippocampus CP Neuroscience Immune checkpoint inhibitors ERRα Pregnancy Demyelination